S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
Log in
NASDAQ:CLVS

Clovis Oncology Earnings Date, Estimates & History

$5.55
-0.17 (-2.97 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.50
Now: $5.55▼
$5.84
50-Day Range
$5.58
MA: $7.24▼
$10.34
52-Week Range
$3.62
Now: $5.55▼
$11.10
Volume7.27 million shs
Average Volume9.23 million shs
Market Capitalization$580.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.1

Earnings

Clovis Oncology (NASDAQ:CLVS) Earnings Information

Clovis Oncology last announced its earnings results on February 22nd, 2021. The biopharmaceutical company reported ($1.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.76) by $0.26. Clovis Oncology has generated ($7.60) earnings per share over the last year. Clovis Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 4th, 2021 based off prior year's report dates.

Clovis Oncology Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Clovis Oncology (NASDAQ:CLVS) Earnings Estimates

2021 EPS Consensus Estimate: ($2.91)
2022 EPS Consensus Estimate: ($1.98)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20213($1.20)($0.62)($0.86)
Q2 20213($1.16)($0.58)($0.78)
Q3 20213($1.15)($0.56)($0.76)
Q4 20212($0.57)($0.45)($0.51)
Q1 20221($0.54)($0.54)($0.54)
Q2 20221($0.51)($0.51)($0.51)
Q3 20221($0.49)($0.49)($0.49)
Q4 20221($0.44)($0.44)($0.44)

Clovis Oncology (NASDAQ CLVS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/4/2021
(Estimated)		       
2/22/202112/31/2020($0.76)($1.02)($0.46)Transcript
11/5/20209/30/2020($1.01)($0.89)($0.89)$42.34 million$38.77 millionTranscript
8/6/20206/30/2020($1.04)($1.15)($1.07)$44.65 million$39.89 millionTranscript
5/5/20203/31/2020($1.28)($1.28)($1.17)$41.80 million$42.56 millionTranscript
2/24/2020Q4 2019($1.71)($1.81)($1.81)$38.79 million$39.31 millionTranscript
11/7/2019Q3($1.89)($1.72)($2.06)$35.84 million$37.60 millionTranscript
8/1/2019Q2 2019($1.70)($2.27)($2.27)$34.92 million$32.98 millionN/A
5/7/20193/31/2019($1.80)($1.63)($1.63)$32.10 million$33.12 millionN/A
2/26/2019Q4 2018($1.68)($1.88)($1.88)$30.46 million$30.40 millionTranscript
10/30/20189/30/2018($1.60)($1.71)($1.71)$30.11 million$22.76 millionN/A
8/1/2018Q2 2018($1.38)($1.94)($1.94)$22.44 million$23.76 millionN/A
5/8/2018Q1 2018($1.36)($1.54)($1.54)$18.34 million$18.50 millionN/A
2/26/2018Q4 2017($1.29)($1.04)($1.50)$19.42 million$17.04 millionTranscript
11/1/2017Q3 2017($1.18)($1.24)($1.24)$21.12 million$16.81 millionN/A
8/2/2017Q2 2017($1.27)($1.29)$1.30$13.07 million$14.62 millionListen
5/3/2017Q1 2017($1.43)($1.33)($1.33)$6.04 million$7.05 millionListen
2/22/2017Q416($1.65)($1.83)($1.83)$0.08 millionListen
11/3/2016Q316($1.95)($1.70)($1.70)Listen
8/8/2016Q216($2.13)($2.07)($0.77)Listen
5/5/2016Q116($2.39)($2.17)($2.17)Listen
2/25/2016Q415($2.39)($2.23)($1.34)Listen
11/5/2015Q315($2.07)($2.62)($2.62)Listen
8/6/2015Q215($2.11)($2.10)($2.10)$1.17 millionListen
5/6/2015Q115($1.78)($1.86)($1.86)$13.60 millionListen
2/25/2015Q414($1.41)($1.62)($1.62)Listen
11/6/2014Q314($1.03)($1.17)($1.17)Listen
8/7/2014Q214($0.93)($1.03)($1.03)$13.60 millionListen
5/8/2014Q114($0.85)($0.91)($0.91)$13.60 millionListen
2/27/2014Q4 2013($0.75)($0.92)($0.92)Listen
10/31/2013Q3 2013($0.63)($0.68)($0.68)Listen
8/1/2013Q2 2013($0.69)($0.72)($0.72)Listen
5/7/2013Q1 2013($0.60)($0.60)($0.60)Listen
2/28/2013Q4 2012($0.76)($0.81)($0.81)N/A
11/5/2012Q3 2012($0.68)($0.71)($0.71)N/A
8/8/2012Q2 2012($0.61)($0.61)($0.61)N/A
5/8/2012Q1 2012($0.81)($0.74)($0.62)N/A
3/7/2012Q4 2011($0.79)($1.30)($1.30)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/4/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.